The retirement of David Cordani as CEO of The Cigna Group will be the fourth departure of a long-time health insurance ...

Humana faces severe headwinds from rising medical costs and a dramatic drop in 4-STAR Medicare Advantage membership, pressuring margins and profitability. Learn more about HUM stock here.

Some seniors were forced to switch insurance providers to keep their doctors. Behind the scenes, a giant health care group is tightening its grip on the market.

UNH's scale and diversified model are likely to offer stronger upside than HUM as rising medical costs test managed care ...

A Healthcare Dive analysis lays out just how drastically insurers retrenched their MA businesses for 2026, with ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $221.8, a high estimate of $313.00, and a low estimate of $158.00. A negative shift in sentiment ...

The addition of 82 owned and affiliated clinics in Florida comes as Humana doubles down on its primary care portfolio.

Humana’s fast-growing CenterWell healthcare services business added another network of senior primary care centers with the ...

Detailed price information for Doximity Inc Cl A (DOCS-N) from The Globe and Mail including charting and trades.

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Humana CEO Jim Rechtin acknowledged the noise around the latest Medicare Advantage rate notice and said that while the flat proposal is a concern, the company will continue to push forward on its ...